Infliximab is a monoclonal antibody that targets and inhibits tumor necrosis factor-alpha (TNF-α). TNF-α is a pro-inflammatory cytokine involved in systemic inflammation and is implicated in various autoimmune diseases. Infliximab is commonly used in the treatment of conditions such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis.
